Your browser is no longer supported. Please, upgrade your browser.
Settings
HTGM HTG Molecular Diagnostics, Inc. daily Stock Chart
HTGM [NASD]
HTG Molecular Diagnostics, Inc.
Index- P/E- EPS (ttm)-0.58 Insider Own12.20% Shs Outstand59.09M Perf Week1.80%
Market Cap36.42M Forward P/E- EPS next Y-0.36 Insider Trans-0.08% Shs Float49.55M Perf Month-0.60%
Income-17.00M PEG- EPS next Q-0.09 Inst Own52.20% Short Float4.91% Perf Quarter-11.87%
Sales22.10M P/S1.65 EPS this Y66.60% Inst Trans-1.79% Short Ratio5.55 Perf Half Y-36.34%
Book/sh0.90 P/B0.68 EPS next Y34.50% ROA-41.00% Target Price2.38 Perf Year-74.11%
Cash/sh0.64 P/C0.96 EPS next 5Y- ROE-88.60% 52W Range0.54 - 3.24 Perf YTD-12.20%
Dividend- P/FCF- EPS past 5Y22.30% ROI-43.00% 52W High-80.98% Beta1.56
Dividend %- Quick Ratio5.10 Sales past 5Y57.20% Gross Margin60.40% 52W Low14.24% ATR0.04
Employees107 Current Ratio5.20 Sales Q/Q14.90% Oper. Margin-75.70% RSI (14)52.62 Volatility7.67% 7.32%
OptionableYes Debt/Eq0.56 EPS Q/Q11.30% Profit Margin-77.00% Rel Volume1.12 Prev Close0.60
ShortableYes LT Debt/Eq0.47 EarningsMar 05 AMC Payout- Avg Volume437.77K Price0.62
Recom1.70 SMA205.44% SMA50-5.67% SMA200-45.02% Volume482,374 Change2.72%
May-16-17Reiterated Rodman & Renshaw Buy $4.50 → $6
Aug-22-16Initiated Rodman & Renshaw Buy $5
Apr-04-16Reiterated Canaccord Genuity Buy $10 → $7
Nov-24-15Reiterated Canaccord Genuity Buy $12 → $10
Aug-24-15Reiterated Canaccord Genuity Buy $17 → $12
Jun-03-15Initiated JMP Securities Mkt Outperform
Jun-02-15Initiated Leerink Partners Outperform $18
Jun-02-15Initiated Canaccord Genuity Buy $17
Feb-19-20 08:00AM  HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conference GlobeNewswire
Feb-11-20 08:00AM  HTG EdgeSeq Mouse mRNA Tumor Response Panel Used by Researchers Targeting Cardiac Fibrosis with Engineered T-cells GlobeNewswire +5.21%
Feb-05-20 08:00AM  HTG EdgeSeq miRNA Whole Transcriptome Assay is Highly Reproducible in Biofluids for Potential Use as a Biomarker GlobeNewswire +6.05%
Jan-28-20 08:00AM  HTG Molecular Diagnostics Receives European Patent Grant Notification for Methods for Subtyping Diffuse Large B-cell Lymphoma GlobeNewswire
Jan-13-20 08:00AM  HTG Molecular Diagnostics Announces Preliminary 2019 Unaudited Financial Results GlobeNewswire -8.18%
07:55AM  Investors Who Bought HTG Molecular Diagnostics (NASDAQ:HTGM) Shares A Year Ago Are Now Down 68% Simply Wall St.
Dec-14-19 06:39PM  Hedge Funds Have Never Been This Bullish On HTG Molecular Diagnostics, Inc. (HTGM) Insider Monkey
Dec-03-19 07:42PM  Edited Transcript of HTGM earnings conference call or presentation 12-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
08:00AM  HTG Molecular Diagnostics to Host Key Opinion Leader Meeting on the Future of Precision Medicine GlobeNewswire
Nov-19-19 08:00AM  HTG Molecular Diagnostics Expands Analytics Capabilities with Release of New Software Update GlobeNewswire
Nov-14-19 06:38AM  Health Check: How Prudently Does HTG Molecular Diagnostics (NASDAQ:HTGM) Use Debt? Simply Wall St.
Nov-12-19 05:55PM  HTG Molecular Diagnostics, Inc. (HTGM) Reports Q3 Loss, Lags Revenue Estimates Zacks
04:01PM  HTG Molecular Diagnostics Reports Third Quarter 2019 Results GlobeNewswire
Nov-08-19 04:30PM  Seven Arizona companies ranked among fastest growing by Deloitte American City Business Journals -5.00%
Nov-05-19 10:32AM  HTG Molecular Diagnostics, Inc. (HTGM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Oct-31-19 08:00AM  HTG Molecular Diagnostics to Announce Third Quarter 2019 Financial Results and Host Conference Call on Tuesday, November 12 GlobeNewswire
Oct-22-19 08:00AM  HTG Molecular Diagnostics to Host Key Opinion Leader Meeting on Breast Cancer Molecular Diagnostics on October 29 GlobeNewswire +6.85%
Oct-15-19 08:00AM  HTG Announces the Launch of its New Autoimmune Profiling Assay GlobeNewswire
Oct-10-19 08:00AM  HTG Molecular Diagnostics, Inc. Provides Update Regarding Companion Diagnostic Development Programs GlobeNewswire
Sep-30-19 08:00AM  HTG Molecular to Present Corporate Overview at the Cantor 2019 Global Healthcare Conference GlobeNewswire +6.94%
Sep-24-19 04:05PM  HTG Molecular Diagnostics Announces Completion of $22.5 Million Aggregate Financing, Consisting of $19.0 Million Public Offering of Common Stock, Including the Exercise in Full of the Underwriters Option to Purchase Additional Shares, and $3.5 Million Concurrent Private Placement GlobeNewswire -10.49%
Sep-20-19 11:02AM  Could HTG Molecular Diagnostics, Inc.'s (NASDAQ:HTGM) Investor Composition Influence The Stock Price? Simply Wall St.
09:28AM  HTG Molecular Diagnostics Announces Pricing of $20.0 Million Aggregate Financing, Consisting of $16.6 Million Public Offering of Common Stock and $3.5 Million Concurrent Private Placement Business Wire
07:46AM  The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering Benzinga
Sep-19-19 04:01PM  HTG Molecular Diagnostics Announces Proposed Public Offering of Common Stock GlobeNewswire
Aug-20-19 04:05PM  HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Aug-13-19 01:26PM  Edited Transcript of HTGM earnings conference call or presentation 6-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-12-19 12:47PM  Edited Transcript of HTGM earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
Aug-06-19 06:15PM  HTG Molecular Diagnostics, Inc. (HTGM) Reports Q2 Loss, Tops Revenue Estimates Zacks
Jul-30-19 10:38AM  Analysts Estimate HTG Molecular Diagnostics, Inc. (HTGM) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-25-19 08:00AM  HTG Molecular to Present Corporate Overview at the Canaccord Genuity 39th Annual Growth Conference GlobeNewswire
Jul-24-19 08:00AM  HTG Molecular Diagnostics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, August 6 GlobeNewswire
Jul-22-19 03:11PM  Investors Who Bought HTG Molecular Diagnostics (NASDAQ:HTGM) Shares A Year Ago Are Now Down 54% Simply Wall St.
Jul-15-19 08:00AM  HTG Expands RUO Profiling Menu with New Platform Compatibility Assays GlobeNewswire
Jul-08-19 08:00AM  HTG Expands Data Analytics Capabilities for Customers with the Release of HTG EdgeSeq Reveal Data Analytics Software Version 1.2.0 GlobeNewswire
Jul-01-19 04:05PM  HTG Presents at the 11th Annual Edition of the Worldwide Innovative Networking (WIN) Symposium GlobeNewswire -9.04%
Jun-07-19 11:35AM  Does HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) Have A High Beta? Simply Wall St.
May-24-19 04:05PM  HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
May-09-19 08:05PM  HTG Molecular Diagnostics, Inc. (HTGM) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:05PM  HTG Molecular Diagnostics Reports First Quarter 2019 Results GlobeNewswire
May-02-19 10:33AM  HTG Molecular Diagnostics, Inc. (HTGM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-30-19 04:05PM  HTG Molecular Diagnostics to Announce First Quarter 2019 Financial Results and Host Conference Call on Thursday, May 9 GlobeNewswire
08:00AM  HTG Molecular Expands Agreement with Illumina to Include Autoimmune, Cardiovascular, and Fibrosis Disorders and Diseases GlobeNewswire
Apr-19-19 08:18AM  HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM): Time For A Financial Health Check Simply Wall St.
Mar-28-19 12:01PM  Edited Transcript of HTGM earnings conference call or presentation 7-Mar-19 9:30pm GMT Thomson Reuters StreetEvents
07:54AM  The Daily Biotech Pulse: Blueprint Medicine Expedites Clinical Programs, Eyepoint Offering, Precision Biosciences IPO Benzinga
Mar-27-19 04:05PM  HTG Introduces the HTG EdgeSeq Mouse mRNA Tumor Response Panel GlobeNewswire
Mar-07-19 04:05PM  HTG Molecular Diagnostics Reports Full Year 2018 Results GlobeNewswire
Feb-22-19 08:00AM  Recent Analysis Shows MGM Resorts International, Symantec, HTG Molecular Diagnostics, Children's Place, Triumph Group, and Sprague Resources LP Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Feb-21-19 04:05PM  HTG Molecular Diagnostics to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on Thursday, March 7 GlobeNewswire +14.29%
08:00AM  HTG Molecular to Present Corporate Overview at the Cowen & Company 39th Annual Health Care Conference GlobeNewswire
Feb-20-19 04:01PM  HTG Molecular Announces an Amendment and Extension to its Precision Diagnostic Partnership (PDP) Two GlobeNewswire -5.18%
08:00AM  HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference GlobeNewswire
Jan-23-19 04:05PM  HTG Molecular Appoints Dr. Joseph Sparano as Lead of Its Clinical Scientific Advisory Board for Breast Cancer Program GlobeNewswire
Jan-16-19 04:05PM  HTG Launches HTG EdgeSeq Reveal GlobeNewswire
Jan-14-19 04:05PM  HTG Molecular Announces Executive Transition Plan GlobeNewswire -6.80%
Jan-07-19 08:00AM  HTG Announces Preliminary Full Year 2018 Unaudited Revenue of Approximately $21.5 Million GlobeNewswire
Dec-18-18 04:01PM  HTG Establishes a French Subsidiary to Support Expanding Growth GlobeNewswire -8.15%
Dec-05-18 07:00AM  TATAA Biocenter Expands Its Next-Generation Sequencing Offerings with HTG Molecular Diagnostics' Unique HTG EdgeSeq System GlobeNewswire
Nov-27-18 08:35AM  Factors of Influence in 2018, Key Indicators and Opportunity within Dillard's, Biohaven Pharmaceutical Holding, HTG Molecular Diagnostics, Strongbridge Biopharma, Myriad Genetics, and Beazer Homes New Research Emphasizes Economic Growth GlobeNewswire
Nov-15-18 01:27PM  Edited Transcript of HTGM earnings conference call or presentation 8-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-12-18 08:00AM  HTG Molecular Presenting at Upcoming Healthcare Conferences GlobeNewswire
Nov-08-18 05:55PM  HTG Molecular Diagnostics, Inc. (HTGM) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:01PM  HTG Molecular Diagnostics Reports Third Quarter 2018 Results GlobeNewswire
Oct-31-18 08:00AM  HTG Molecular Appoints Dr. Maureen T. Cronin as Chief Scientific Officer and Senior Vice President GlobeNewswire
Oct-25-18 04:05PM  HTG Molecular Diagnostics to Announce Third Quarter and Nine Months Ended September 30, 2018 Financial Results and Host Conference Call on Thursday, November 8 GlobeNewswire +5.34%
Oct-23-18 04:01PM  HTG Molecular Diagnostics Announces the Institute of Oncology Research Has Adopted the HTG EdgeSeq Technology in its Genomics Facility GlobeNewswire
Oct-16-18 07:25AM  Recent Analysis Shows Professional Diversity Network, Quanex Building Products, HTG Molecular Diagnostics, La Jolla Pharmaceutical, Playa Hotels & Resorts N.V, and Plexus Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Sep-27-18 04:05PM  HTG Molecular Announces Extension to Precision Diagnostic Partnership (PDP) Program Three for Companion Diagnostic Submission GlobeNewswire
Sep-26-18 04:01PM  HTG Molecular to Present a Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference GlobeNewswire +10.39%
Aug-31-18 04:33PM  Indexes Hold Onto Week's Gains TheStreet.com +8.45%
Aug-30-18 04:05PM  HTG Molecular to Present a Corporate Overview at the H.C. Wainwright 20th Annual Global Investment Conference GlobeNewswire
Aug-29-18 08:00AM  HTG Introduces the HTG EdgeSeq Mouse miRNA Whole Transcriptome Assay, a Comprehensive Panel for miRNA Expression Analysis for use in Translational Medicine and Preclinical Studies GlobeNewswire
Aug-20-18 08:00AM  HTG Molecular Announces 2nd Amendment to Second Statement of Work with QIAGEN Manchester Limited GlobeNewswire
Aug-19-18 04:49AM  Edited Transcript of HTGM earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-16-18 04:01PM  HTG Molecular Appoints Michelle R. Griffin to its Board of Directors GlobeNewswire
Aug-15-18 04:01PM  HTG Molecular Diagnostics Fulfills First Orders for its Next-Generation Sequencing-Based HTG EdgeSeq Precision Immuno-Oncology Panel GlobeNewswire
07:35AM  Detailed Research: Economic Perspectives on Neos Therapeutics, Federated National Holding, FutureFuel, Golden Entertainment, Intra-Cellular Therapies, and HTG Molecular Diagnostics What Drives Growth in Today's Competitive Landscape GlobeNewswire
Aug-09-18 08:00AM  HTG Molecular Announces Amendment to Second Statement of Work with QIAGEN Manchester Limited GlobeNewswire
Aug-08-18 01:40PM  Two Small Caps On the Cusp of Being Discovered TheStreet.com +24.74%
Aug-07-18 08:15PM  HTG Molecular Diagnostics, Inc. (HTGM) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:05PM  HTG Molecular Diagnostics Reports Second Quarter 2018 Results GlobeNewswire
02:30PM  HTG Molecular Diagnostics, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-18 08:30AM  HTG Molecular Diagnostics and Oncologie, Inc. Complete Master Agreement to Partner on Biomarker Development for Immuno-oncology Drug Development GlobeNewswire
Aug-01-18 04:01PM  HTG Molecular Diagnostics to Present at Canaccord Genuity Growth Conference GlobeNewswire
Jul-24-18 08:00AM  HTG Molecular Diagnostics to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on Tuesday, August 7 GlobeNewswire -6.12%
Jun-26-18 01:54PM  HTG Molecular Diagnostics Incs (NASDAQ:HTGM) Shift From Loss To Profit Simply Wall St.
Jun-20-18 07:15AM  Free Stock Performance Review on Agilent Technologies and Three Additional Medical Research Stocks ACCESSWIRE
May-31-18 03:44PM  Penny Stocks to Watch for June 2018 Investopedia
May-10-18 04:01PM  HTG Molecular Diagnostics Reports First Quarter 2018 Results GlobeNewswire
08:59AM  Does HTG Molecular Diagnostics Incs (NASDAQ:HTGM) Latest Financial Perfomance Look Strong? Simply Wall St.
08:00AM  HTG Molecular Diagnostics to Feature Its HTG EdgeSeq Precision Immuno-Oncology Panel at Booth #4113 at the American Society of Clinical Oncology (ASCO) Conference in June 2018 GlobeNewswire
May-07-18 08:00AM  HTG Molecular Diagnostics and Firalis Announce an Agreement Enabling Firalis Commercialization of Theranostic and Research Products and Services Based on HTG EdgeSeq Technology GlobeNewswire +5.98%
May-02-18 07:30AM  New Research: Key Drivers of Growth for HTG Molecular Diagnostics, Impinj, XOMA, Stock Yards, TriCo Bancshares, and Alleghany Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Apr-27-18 04:01PM  HTG Molecular Diagnostics to Announce First Quarter Financial Results and Host Conference Call on Thursday, May 10 GlobeNewswire
Apr-16-18 04:15PM  HTG Promotes John Lubniewski to President and Chief Operating Officer GlobeNewswire
Apr-03-18 08:00AM  HTG Announces New Patent for Its Technology Issued in Japan GlobeNewswire
Mar-27-18 08:00AM  HTG Molecular Diagnostics Secures Debt Facility with MidCap Financial GlobeNewswire
Mar-23-18 07:23AM  3 Stocks to Watch on Friday: At Home Group Inc (HOME), HTG Molecular Diagnostics Inc (HTGM) and iCAD Inc (ICAD) InvestorPlace -17.07%
Mar-22-18 04:01PM  HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2017 Results GlobeNewswire
HTG Molecular Diagnostics, Inc. a commercial stage life sciences company, focuses on the precision medicine. The company offers instrumentation (or platforms); consumables comprising assay kits; and software analytics that automate sample processing and profiles various molecular targets. Its platforms generate a molecular profiling library for detection using next-generation sequencing. The company's assay product offerings include HTG EdgeSeq oncology biomarker panel; HTG EdgeSeq immuno-oncology assay; HTG EdgeSeq DLBCL Cell of Origin Assay; HTG EdgeSeq PATH Assay; HTG EdgeSeq miRNA Whole-Transcriptome Assay; HTG EdgeSeq DLBCL Cell of Origin Assay EU; HTG EdgeSeq ALKPlus Assay EU; HTG EdgeSeq EGFR, KRAS and BRAF Mutation Assay; and HTG EdgeSeq Precision Immuno-Oncology Panel. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. The company has a collaboration agreement with Bristol-Myers Squibb for the development of custom RUO assays; governing agreement with QIAGEN Manchester Limited; development and professional services agreement with Invetech PTY Ltd; and an agreement with Illumina, Inc. for the development of nuclease-protection-based RNA or DNA profiling tests. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JOHNSON TIM BExecutive ChairmanDec 26Sale0.725,7184,110256,121Jan 02 04:53 PM